These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 16889567)

  • 21. Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS).
    Bragg-Gresham JL; Fissell RB; Mason NA; Bailie GR; Gillespie BW; Wizemann V; Cruz JM; Akiba T; Kurokawa K; Ramirez S; Young EW
    Am J Kidney Dis; 2007 Mar; 49(3):426-31. PubMed ID: 17336704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study.
    Johnson ES; Thorp ML; Platt RW; Smith DH
    Am J Kidney Dis; 2008 Oct; 52(4):653-60. PubMed ID: 18585833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adequacy of peritoneal dialysis and the importance of preserving residual renal function.
    van den Wall Bake AW; Kooman JP; Lange JM; Smit W
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 2():ii34-7. PubMed ID: 16825258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PD and HD in combination.
    Dell Aquila R; Ronco C
    Nefrologia; 2008; 28 Suppl 6():67-70. PubMed ID: 18957015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2007; 23():135-9. PubMed ID: 17886620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biological adequacy--what does it mean?].
    Kes P; Basić-Jukić N; Brunetta B
    Acta Med Croatica; 2004; 58(1):1-4. PubMed ID: 15125386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis.
    Lin YF; Huang JW; Wu MS; Chu TS; Lin SL; Chen YM; Tsai TJ; Wu KD
    Nephrology (Carlton); 2009 Feb; 14(1):59-64. PubMed ID: 19019171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous iron does not affect the rate of decline of residual renal function in patients on peritoneal dialysis.
    Shah H; Shukla A; Krishnan A; Pliakogiannis T; Ahmad M; Bargman JM; Oreopoulos DG
    Adv Perit Dial; 2006; 22():99-103. PubMed ID: 16983949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of furosemide in patients on peritoneal dialysis.
    Flinn A; Ledger S; Blake P
    CANNT J; 2006; 16(3):40-4. PubMed ID: 17061696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A partial explanation for the surprising ADEMEX result.
    Pagé DE; Knoll G
    Adv Perit Dial; 2003; 19():73-6. PubMed ID: 14763037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of body mass index with decline in residual kidney function after initiation of dialysis.
    Drechsler C; de Mutsert R; Grootendorst DC; Boeschoten EW; Krediet RT; le Cessie S; Wanner C; Dekker FW;
    Am J Kidney Dis; 2009 Jun; 53(6):1014-23. PubMed ID: 19217702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical benefit of preserving residual renal function in dialysis patients: an update for clinicians.
    Brener ZZ; Kotanko P; Thijssen S; Winchester JF; Bergman M
    Am J Med Sci; 2010 May; 339(5):453-6. PubMed ID: 20375877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients.
    Voormolen N; Noordzij M; Grootendorst DC; Beetz I; Sijpkens YW; van Manen JG; Boeschoten EW; Huisman RM; Krediet RT; Dekker FW;
    Nephrol Dial Transplant; 2007 Oct; 22(10):2909-16. PubMed ID: 17517792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Patients in pre-dialysis: decision taking and free choice of treatment].
    Sarrias Lorenz X; Bardón Otero E; Vila Paz ML
    Nefrologia; 2008; 28 Suppl 3():119-22. PubMed ID: 19018749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients.
    Ignace S; Fouque D; Arkouche W; Steghens JP; Guebre-Egziabher F
    Nephrol Dial Transplant; 2009 May; 24(5):1685-9. PubMed ID: 19276104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes after failed renal transplantation-does dialysis modality matter?
    Perl J; Bargman JM; Davies SJ; Jassal SV
    Semin Dial; 2008; 21(3):239-44. PubMed ID: 18533967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical impact of residual function in haemodialysis.
    Carofei O; Galeotti P; Satriani M; Pedulla F; Taratufolo A
    EDTNA ERCA J; 1997; 23(3):54-6. PubMed ID: 9664012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease.
    Tanriover C; Ucku D; Basile C; Tuttle KR; Kanbay M
    J Nephrol; 2022 Dec; 35(9):2191-2204. PubMed ID: 35819749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.